SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 17th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 15, 2024, between Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), Psyence Biomed II Corp., a corporation existing under the laws of Ontario, Canada (“Psyence”), the funds, accounts, and/other investment vehicles managed by [ ] signatory hereto (collectively, the “Purchaser” and collectively with the Company and Psyence, the “Parties”), and Newcourt SPAC Sponsor LLC (“Sponsor”).
